---
schema_version: "secwatch.filing_event.v1"
accession: "0000877860-23-000087"
form_type: "8-K"
ticker: "NHI"
cik: "0000877860"
company_name: "NATIONAL HEALTH INVESTORS INC"
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T03:24:35.897662+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NHI reports Q2 net income $0.92/share, cuts full-year Normalized FFO guidance

## Summary
- Net income per diluted share $0.92 (vs $0.47); NAREIT FFO $1.05 (vs $0.71); Normalized FFO $1.06 (vs $1.27).
- Normalized FAD Q2 $44.6M (vs $56.3M); six-month $92.3M (vs $109.0M).
- FY2023 Normalized FFO guidance cut to $4.31-$4.35 from $4.37-$4.42; FAD guidance cut to $185-$186.8M from $186.3-$188.9M.
- Sold six properties in Q2 for net proceeds ~$39.1M; one more in Q3 for ~$2.9M.
- Net debt to adj. EBITDA 4.6x; $196M drawn on $700M revolver; new $200M term loan placed.

## SEC filing metadata
- accession: 0000877860-23-000087
- form_type: 8-K
- ticker: NHI
- cik: 0000877860
- company_name: NATIONAL HEALTH INVESTORS INC
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/877860/000087786023000087/0000877860-23-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/877860/000087786023000087/nhi-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000877860-23-000087
- JSON: https://secwatch.observer/filing/0000877860-23-000087.json
- Plain text: https://secwatch.observer/filing/0000877860-23-000087.txt

## Key facts
- Earnings Releases
  NATIONAL HEALTH INVESTORS INC reported three and six months ended June 30, 2023 results: EPS Net income attributable to common stockholders per diluted common share for the three months ended June 30, 2023 was $0.. Guidance reaffirmed.
  - Period: three and six months ended June 30, 2023
  - EPS: Net income attributable to common stockholders per diluted common share for the three months ended June 30, 2023 was $0.
  - Guidance: reaffirmed
  - Result: reported results
  source text: NHI Announces Second Quarter 2023 Results MURFREESBORO, Tenn. – (August 8, 2023) National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and six months ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/877860/000087786023000087/0000877860-23-000087-index.htm
- Earnings Releases
  NATIONAL HEALTH INVESTORS INC reported 2023 results: EPS Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42. Guidance lowered.
  - Period: 2023
  - EPS: Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42
  - Guidance: lowered
  - Result: guidance update
  source text: NHI is revising its 2023 annual guidance range for Normalized FFO per share to $4.31 - $4.35 from $4.37 - $4.42 and is revising Normalized FAD to a range of $185.0 million - $186.8 million from $186.3 million - $188.9 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/877860/000087786023000087/0000877860-23-000087-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.